OpenVSafe by OpenVAERS
Search V-safe

ET6-26026-27929

4 vaccinations 4 coded responses 40 check-ins 4 free-text entries 1 call case
Sex
Male
Age at first dose
66+
ZIP prefix
750 / TX
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-01-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  22. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  23. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-10-15
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-10-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-10-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-11-05
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-11-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-12-31
    Survey response — 3 months, dose 3
    MedDRA: Diarrhoea, Magnetic resonance imaging abnormal, Mass, Oedema peripheral — Feeling: Good
    Free text: Diarrhea for two days Lower leg edema with MRI findings of mass with upcoming appointment with specialist in sarcoma
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-04-01
    Survey response — 6 months, dose 3
    MedDRA: Pleomorphic liposarcoma, Radiotherapy — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Pleomorphic liposarcoma with current radiation treatment and future surgery
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-05-14
    Dose 4 — Pfizer-BioNTech
  33. 2022-05-15
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  34. 2022-05-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  35. 2022-05-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-05-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  37. 2022-05-23
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  38. 2022-05-28
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-06-04
    Survey response — day 21, dose 4
    MedDRA: Blood glucose increased, Pleomorphic liposarcoma, Procedural pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Above the knee amputation for paleomorphic liposarcoma on 05.31.2022 with associated postoperative pain and excessive glucose.
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-06-11
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-06-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-06-25
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-08-13
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-11-12
    Survey response — 6 months, dose 4
    MedDRA: Chemotherapy, Hospitalisation, Pyrexia, Tremor — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Chemotherapy first round followed in one week of uncontrollable tremors & high fever resolved with antibiotics with hospitalization
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-11-12
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  46. 2022-11-14
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  47. 2023-05-14
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-08Pfizer-BioNTech
32021-10-01Pfizer-BioNTech No
42022-05-14Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Diarrhea for two days Lower leg edema with MRI findings of mass with upcoming appointment with specialist in sarcoma

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Pleomorphic liposarcoma with current radiation treatment and future surgery

Release 11 — day 21, dose 4

2022-06-04

Symptoms: Above the knee amputation for paleomorphic liposarcoma on 05.31.2022 with associated postoperative pain and excessive glucose.

Release 12 — 6 months, dose 4

2022-11-12

Symptoms: Chemotherapy first round followed in one week of uncontrollable tremors & high fever resolved with antibiotics with hospitalization

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood glucose increased · · ✓
SDChemotherapy · · ✓
SDDiarrhoea · · ✓
SDHospitalisation · · ✓
SDMagnetic resonance imaging abnormal · · ✓
SDMass · · ✓
SDOedema peripheral · · ✓
SDPleomorphic liposarcoma · · ✓
SDProcedural pain · · ✓
SDPyrexia · · ✓
SDRadiotherapy · · ✓
SDTremor · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release